These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

689 related items for PubMed ID: 19365816

  • 21. HLA class II antibodies in transfusion-related acute lung injury (TRALI). A case report.
    Lydaki E, Bolonaki E, Nikoloudi E, Chalkiadakis E, Iniotaki-Theodoraki A.
    Transfus Apher Sci; 2005 Oct; 33(2):107-11. PubMed ID: 16115801
    [Abstract] [Full Text] [Related]

  • 22. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
    Eder AF, Dy BA, O'Neill EM.
    Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
    [Abstract] [Full Text] [Related]

  • 23. Screening for HLA antibodies in plateletpheresis donors with a history of transfusion or pregnancy.
    De Clippel D, Baeten M, Torfs A, Emonds MP, Feys HB, Compernolle V, Vandekerckhove P.
    Transfusion; 2014 Dec; 54(12):3036-42. PubMed ID: 24863861
    [Abstract] [Full Text] [Related]

  • 24. Pulmonary pathology of rapidly fatal transfusion-related acute lung injury reveals minimal evidence of diffuse alveolar damage or alveolar granulocyte infiltration.
    Danielson C, Benjamin RJ, Mangano MM, Mills CJ, Waxman DA.
    Transfusion; 2008 Nov; 48(11):2401-8. PubMed ID: 18673344
    [Abstract] [Full Text] [Related]

  • 25. Low-risk transfusion-related acute lung injury donor strategies and the impact on the onset of transfusion-related acute lung injury: a meta-analysis.
    Müller MC, van Stein D, Binnekade JM, van Rhenen DJ, Vlaar AP.
    Transfusion; 2015 Jan; 55(1):164-75. PubMed ID: 25135630
    [Abstract] [Full Text] [Related]

  • 26. Transfusion related acute lung injury (TRALI) caused by red blood cell transfusion involving residual plasma anti-HLA antibodies: a report on two cases and general considerations.
    Odent-Malaure H, Quainon F, Ruyer-Dumontier P, Ducroz S, Verdier P, Voitellier E, Raynal MF, Fromont P, Muller JY, Rebibo D, Absi L, Garraud O.
    Clin Dev Immunol; 2005 Dec; 12(4):243-8. PubMed ID: 16584109
    [Abstract] [Full Text] [Related]

  • 27. Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies.
    Curtis BR, McFarland JG.
    Crit Care Med; 2006 May; 34(5 Suppl):S118-23. PubMed ID: 16617255
    [Abstract] [Full Text] [Related]

  • 28. Implementation and outcomes of a transfusion-related acute lung injury surveillance programme and study of HLA/HNA alloimmunisation in blood donors.
    Porretti L, Cattaneo A, Coluccio E, Mantione E, Colombo F, Mariani M, Bottelli G, Mazzucchelli S, Pappalettera M, Speranza T, Migliari M, Cambié G, Prati D, Rebulla P.
    Blood Transfus; 2012 Jul; 10(3):351-9. PubMed ID: 22395353
    [Abstract] [Full Text] [Related]

  • 29. Conversion to low transfusion-related acute lung injury (TRALI)-risk plasma significantly reduces TRALI.
    Arinsburg SA, Skerrett DL, Karp JK, Ness PM, Jhang J, Padmanabhan A, Gibble J, Schwartz J, King KE, Cushing MM.
    Transfusion; 2012 May; 52(5):946-52. PubMed ID: 22060800
    [Abstract] [Full Text] [Related]

  • 30. Transfusion-related acute lung injury: a change of perspective.
    Vlaar AP, Schultz MJ, Juffermans NP.
    Neth J Med; 2009 Nov; 67(10):320-6. PubMed ID: 19915225
    [Abstract] [Full Text] [Related]

  • 31. TRALI-new challenges for histocompatibility and immunogenetics in transfusion medicine.
    Flesch BK, Petershofen EK, Bux J.
    Tissue Antigens; 2011 Jul; 78(1):1-7. PubMed ID: 21658007
    [Abstract] [Full Text] [Related]

  • 32. Implementation of a strategy to prevent TRALI in a regional blood centre.
    Insunza A, Romon I, Gonzalez-Ponte ML, Hoyos A, Pastor JM, Iriondo A, Hermosa V.
    Transfus Med; 2004 Apr; 14(2):157-64. PubMed ID: 15113380
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Transfusion-related acute lung injury caused by two donors with anti-human leucocyte antigen class II antibodies: a look-back investigation.
    Nicolle AL, Chapman CE, Carter V, Wallis JP.
    Transfus Med; 2004 Jun; 14(3):225-30. PubMed ID: 15180814
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Storage time of blood products and transfusion-related acute lung injury.
    Middelburg RA, Borkent-Raven BA, Janssen MP, van de Watering LM, Wiersum-Osselton JC, Schipperus MR, Beckers EA, Briët E, van der Bom JG.
    Transfusion; 2012 Mar; 52(3):658-67. PubMed ID: 21950582
    [Abstract] [Full Text] [Related]

  • 39. Diagnosis of transfusion-related acute lung injury: TRALI or not TRALI?
    Fontaine MJ, Malone J, Mullins FM, Grumet FC.
    Ann Clin Lab Sci; 2006 Mar; 36(1):53-8. PubMed ID: 16501237
    [Abstract] [Full Text] [Related]

  • 40. [Analysis of transfusion related acute lung injuries after donor plasma transfusion in obstetrics].
    Appalup MV, Rogachevskiĭ OV, Fedorova TA, Sokologorskiĭ SV.
    Anesteziol Reanimatol; 2010 Mar; (6):51-5. PubMed ID: 21404450
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.